5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.44▼ | 1.47▼ | 1.52▼ | 1.92▼ | 2.02▼ |
MA10 | 1.48▼ | 1.56▼ | 1.73▼ | 2.08▼ | 2.37▼ |
MA20 | 1.65▼ | 1.86▼ | 1.95▼ | 2.13▼ | 3.13▼ |
MA50 | 1.97▼ | 2.16▼ | 2.27▼ | 2.47▼ | 4.68▼ |
MA100 | 2.33▼ | 2.42▼ | 2.50▼ | 3.30▼ | 5.58▼ |
MA200 | 2.74▼ | 2.89▼ | 3.00▼ | 4.41▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.037▼ | -0.059▼ | -0.045▼ | -0.067▼ |
RSI | 24.721▼ | 15.072▼ | 16.273▼ | 22.221▼ | 28.898▼ |
STOCH | 4.572▼ | 3.201▼ | 3.050▼ | 24.828 | 11.256▼ |
WILL %R | -92.857▼ | -97.468▼ | -97.647▼ | -98.077▼ | -99.228▼ |
CCI | -97.258 | -85.002 | -104.563▼ | -294.564▼ | -153.818▼ |
Wednesday, May 15, 2024 10:42 AM
Shares of BriaCell Therapeutics (NASDAQ:BCTX) came under pressure on Wednesday after the cancer drug developer announced plans to raise approximately $5M by issuing common shares and pre-funded ...
|
Wednesday, May 15, 2024 05:01 AM
PHILADELPHIA and VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops ...
|
Wednesday, May 15, 2024 05:01 AM
PHILADELPHIA and VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 1.64 | 1.64 | 1.40 | 1.42 | 342,808 |
15/05/24 | 2.00 | 2.0523 | 1.6075 | 1.63 | 301,244 |
14/05/24 | 2.18 | 2.2427 | 2.09 | 2.11 | 28,536 |
13/05/24 | 2.19 | 2.19 | 2.19 | 2.19 | 16,064 |
10/05/24 | 2.2401 | 2.31 | 2.23 | 2.25 | 6,058 |
09/05/24 | 2.23 | 2.44 | 2.1601 | 2.26 | 58,188 |
08/05/24 | 2.252 | 2.3188 | 2.1901 | 2.24 | 12,267 |
07/05/24 | 2.24 | 2.28 | 2.19 | 2.19 | 14,472 |
06/05/24 | 2.275 | 2.2857 | 2.21 | 2.27 | 11,865 |
03/05/24 | 2.25 | 2.34 | 2.23 | 2.26 | 28,649 |
|
|
||||
|
|
||||
|
|